Zachariae, H. Methotrexate side-effects. Br. J. Dermatol. 122 (Suppl. 36), 127–133 (1990).

Article  PubMed  Google Scholar 

Whiting-O’Keefe, Q. E., Fye, K. H. & Sack, K. D. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am. J. Med. 90, 711–716 (1991).

Article  PubMed  Google Scholar 

Arena, U. et al. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. Dig. Liver Dis. 44, 149–153 (2012).

Article  CAS  PubMed  Google Scholar 

Atallah, E. et al. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. J. Hepatol. https://doi.org/10.1016/j.jhep.2022.12.034 (2023).

Article  PubMed  Google Scholar 

Vali, Y. et al. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis. J. Hepatol. 73, 252–262 (2020).

Article  PubMed  Google Scholar 

Selvaraj, E. A. et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J. Hepatol. 75, 770–785 (2021).

Article  PubMed  Google Scholar 

Warren, R. B. et al. British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. Br. J. Dermatol. 175, 23–44 (2016).

Article  CAS  PubMed  Google Scholar